Literature DB >> 15214046

Gene expression profile of B cells from Xid mice and Btk knockout mice.

Jessica M Lindvall1, K Emelie M Blomberg, Anna Berglöf, Qian Yang, C I Edvard Smith, Tahmina C Islam.   

Abstract

Bruton's tyrosine kinase (Btk) is important for B lymphocyte development. To identify genes that are differentially expressed in primary B cells lacking functional Btk, splenocytes from X-linked immunodeficiency (Xid), Btk knockout (Btk KO) and immunocompetent CBA mice were used in microarrays containing more than 12000 genes and expressed-sequence tags. We found 4515 common transcripts expressed in duplicate experiments in the three strains. Out of these, 38 were differentially expressed genes (21 were up-regulated >2-fold and 17 were down-regulated <-2-fold) between CBA and Btk defective (Xid or Btk KO) mice. Ten out of these genes were selected and quantitative real-time PCR was conducted for validation and further investigation. Real-time experiments correlated nicely with the microarray data. No definitive phenotypic difference has previously been reported between Xid and Btk KO mice. We found 7 genes whose expression differed (>2-fold) between the two strains. Moreover, when the 38 genes that differed between immunocompetent CBA mice and Btk defective mice were ranked according to fold-increase, the levels in Btk KO mice were significantly more altered. This suggests that the defect in Btk KO mice is more severe and demonstrates that the mutant Btk protein in Xid mice does not generally function as dominant-negative form.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15214046     DOI: 10.1002/eji.200324051

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice.

Authors:  Maroof Hasan; Gabriela Lopez-Herrera; K Emelie M Blomberg; Jessica M Lindvall; Anna Berglöf; C I Edvard Smith; Leonardo Vargas
Journal:  Immunology       Date:  2007-08-28       Impact factor: 7.397

2.  Tollip-induced down-regulation of MARCH1.

Authors:  Marie-Claude Bourgeois-Daigneault; Abdul Mohammad Pezeshki; Tristan Galbas; Mathieu Houde; Martin Baril; Klaus Früh; Abdelaziz Amrani; Satoshi Ishido; Daniel Lamarre; Jacques Thibodeau
Journal:  Results Immunol       Date:  2013-02-20

3.  Bruton's Tyrosine Kinase Deficiency Ameliorates Antimicrobial Host Defense during Peritonitis Induced by Pathogenic Escherichia coli.

Authors:  Zhe Liu; Cornelis van 't Veer; Rudi W Hendriks; Joris J T H Roelofs; Tom van der Poll; Alex F de Vos
Journal:  Infect Immun       Date:  2022-05-19       Impact factor: 3.609

4.  Constitutive activity of the human TRPML2 channel induces cell degeneration.

Authors:  Shaya Lev; David A Zeevi; Ayala Frumkin; Vered Offen-Glasner; Gideon Bach; Baruch Minke
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

5.  Dual phosphorylation of Btk by Akt/protein kinase b provides docking for 14-3-3ζ, regulates shuttling, and attenuates both tonic and induced signaling in B cells.

Authors:  Dara K Mohammad; Beston F Nore; Alamdar Hussain; Manuela O Gustafsson; Abdalla J Mohamed; C I Edvard Smith
Journal:  Mol Cell Biol       Date:  2013-06-10       Impact factor: 4.272

6.  Differential evolutionary wiring of the tyrosine kinase Btk.

Authors:  Hossain M Nawaz; Per Kylsten; Noriko Hamada; Daisuke Yamamoto; C I Edvard Smith; Jessica M Lindvall
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

7.  Transcriptional signatures of Itk-deficient CD3+, CD4+ and CD8+ T-cells.

Authors:  K Emelie M Blomberg; Nicole Boucheron; Jessica M Lindvall; Liang Yu; Julia Raberger; Anna Berglöf; Wilfried Ellmeier; Ci Edvard Smith
Journal:  BMC Genomics       Date:  2009-05-18       Impact factor: 3.969

8.  The Expression of CD9 and PIK3CD is Associated with Prognosis of Follicular Lymphoma.

Authors:  Tieying Dong; Zhaoliang Liu; Shu Zhao; Chengyi Hu; Yupeng Liu; WenJie Ma; Qingyuan Zhang
Journal:  J Cancer       Date:  2015-10-15       Impact factor: 4.207

9.  Covalent Cysteine Targeting of Bruton's Tyrosine Kinase (BTK) Family by Withaferin-A Reduces Survival of Glucocorticoid-Resistant Multiple Myeloma MM1 Cells.

Authors:  Emilie Logie; Chandra S Chirumamilla; Claudina Perez-Novo; Priyanka Shaw; Ken Declerck; Ajay Palagani; Savithri Rangarajan; Bart Cuypers; Nicolas De Neuter; Fazil Mobashar Hussain Urf Turabe; Navin Kumar Verma; Annemie Bogaerts; Kris Laukens; Fritz Offner; Pieter Van Vlierberghe; Xaveer Van Ostade; Wim Vanden Berghe
Journal:  Cancers (Basel)       Date:  2021-03-31       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.